You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
18 August 2026 - Global biopharmaceutical company Harbour BioMed (HKEX: 02142), which develops antibody therapeutics in immunology and oncology, said on Tuesday that China's National Medical Products Administration (NMPA) has approved its Invest...
18 August 2026 - American multinational medical devices and health care company Abbott (NYSE: ABT) and the National Association of Community Health Centers (NACHC) announced on Monday a multi-year 'food is medicine' effort, called the NACHC...
18 August 2026 - Leal Therapeutics, Inc., a US-based clinical-stage biopharmaceutical company developing neuro-metabolic therapeutics, announced on Monday a second close of USD30m of its Series A financing.The round includes new investor Eli Lilly an...
17 August 2026 - Israel-based clinical-stage biotechnology company Can-Fite BioPharma Ltd. (NYSE American: CANF; TASE: CANF), which develops small-molecule drugs for oncological and inflammatory diseases, on Monday reported new preclinical findings s...
17 August 2026 - Biopharmaceutical and medical device company Galmed Pharmaceuticals Ltd (NASDAQ: GLMD) on Monday reported preclinical results showing that Aramchol combined with enzalutamide produced a three- to four-fold increase in prostate cancer...
17 August 2026 - Healthcare enterprise platform Azra AI and 4DMedical Limited (ASX: 4DX), a provider of quantitative lung imaging analytics, on Monday announced a strategic OEM and reseller partnership to provide health systems with enterprise-wide l...
17 August 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) on Monday announced positive high-level results from the SAFFRON Phase III trial, showing Tagrisso (osimertinib) plus Orpathys (savolitinib) delivered statistica...